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arginine-scanning mutagenesis in combination with surface plasmon resonance assays. Our obser-
vation that substitution of some residues of WIF resulted in an increased afﬁnity for Wnt5a, but
decreased afﬁnity for Wnt3a, suggests that these residues may deﬁne the speciﬁcity spectrum of
WIF for Wnts. These results hold promise for a more speciﬁc targeting of Wnt family members with
WIF variants in various forms of cancer.
Structured summary of protein interactions:
WIF binds to Wnt7a by surface plasmon resonance (View Interaction)
WIF binds to Wnt4 by surface plasmon resonance (View Interaction)
WIF and Wnt3a physically interact by competition binding (View Interaction 1, 2, 3, 4,5, 6)
WIF binds to Wnt9b by surface plasmon resonance (View Interaction)
WIF binds to Wnt5a by surface plasmon resonance (View Interaction)
WIF binds to Wnt11 by surface plasmon resonance (View Interaction)
WIF binds to Wnt3a by surface plasmon resonance (View Interaction)
Wnt-5a and WIF physically interact by competition binding (View Interaction 1,2, 3, 4, 5, 6)
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Wnt proteins are large glycosylated, palmitoylated extracellular
molecules that play crucial roles in embryonic development and
stem-cell proliferation throughout the animal kingdom [1,2]. Wnts
elicit their effects through the activation of different intracellular
signal transduction pathways [3]. In the case of the Wnt-b-catenin
pathway Wnts form ternary complexes with Frizzled-type recep-
tors and low-density lipoprotein receptor-related proteins 5 or 6
[4]. Until recently, very little was known about the Wnt structures
that are crucial for their signaling activity, but it was clear that
fatty acid modiﬁcation is a sine qua non of this activity [5,6].
The activity of Wnts is regulated by a variety of secreted extra-
cellular proteins that interfere with the formation of the Wnt-
receptor complexes [7,8]. Members of the Dickkopf family bind
to LRP5/6 and prevent association of the receptor with Wnt,
whereas Cerberus, Wnt Inhibitory Factor-1 and members of the se-
creted frizzled-related protein family bind directly to Wnts and
prevent their binding to the receptor complex.chemical Societies. Published by E
mology, Research Centre for
olina út 29, H-1113 Budapest,The importance of these Wnt-antagonists in the maintenance of
tissue homeostasis is underlined by the fact that epigenetic silenc-
ing of Wnt inhibitory factor-1, soluble Frizzled-related proteins
and Dickkopf proteins is associated with aberrant activation of
the Wnt-b-catenin pathway in a variety of cancers, whereas resto-
ration of their expression inhibits tumor progression [8].
In view of the role of aberrant activation of the Wnt-b-catenin
pathway in various cancers, there is a growing interest in develop-
ing therapies that target Wnt-b-catenin signaling [8,9]. Research in
this area has demonstrated that inhibition of Wnt signaling by
treatment with antibodies against Frizzled, Wnts or by transfection
with vectors coding for soluble Frizzled-related proteins or WIF-1
or treatment with recombinant WIF-domain reduced tumor
growth in several models [8,10]. Based on its signiﬁcant anti-tumor
and anti-metastasis effects in vivo in animal models of osteosar-
coma, WIF-1 represents a promising target for developing thera-
peutic and preventive strategies against metastatic osteosarcoma
with aberrant Wnt signaling [11].
Wnt inhibitory factor-1 is a secreted protein composed of a
WIF-domain [12] and ﬁve EGF repeats. In an assay for Wnt
inhibition, the WIF-domain of human WIF-1 was as effective as
the full-length protein, suggesting that this domain is primarily
responsible for Wnt binding [13], although a recent study suggests
that the EGF domains may have a minor role supporting Wnt
binding to the WIF domain [14].lsevier B.V. All rights reserved.
Table 1
Kinetic parameters of the interaction of Wnt3a, Wnt4, Wnt5a, Wnt7a, Wnt9b and
Wnt11 with immobilized wild type WIF-domain of Wnt Inhibitory factor-1. The rate
constants of the association and dissociation reactions and the equilibrium dissoci-
ation constants of the interactions were determined from surface plasmon resonance
measurements with the BIAevaluation software 4.1.
Interacting proteins Kd(M) ka(1/Ms) kd(1/s)
WIF-Wnt3a 4.0  109 1.5  105 6.0  104
WIF-Wnt4 2.2  109 1.1  105 2.4  104
WIF-Wnt5a 7.8  1010 1.4  105 1.1  104
WIF-Wnt7a 2.9  109 1.1  105 3.2  104
WIF-Wnt9b 1.3  109 1.1  105 1.5  104
WIF-Wnt11 1.6  109 2.8  105 4.4  104
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sional structure of the WIF-domain of human WIF-1 by NMR spec-
troscopy [15]. Our studies have identiﬁed an alkyl-binding site on
the WIF-domain and we have suggested that this site might serve
to interact with the essential palmitoyl-groups of Wnts. In the
present work we have tested this hypothesis by structure-guided
site-directed mutagenesis of the WIF-domain in combination with
surface plasmon resonance assays.
Our studies suggest that a surface involved in Wnt-binding
overlaps with the alkyl-binding site of the WIF-domain. Our muta-
genesis studies have also shown that substitution of some residues
of WIF resulted in an increased afﬁnity for Wnt5a, but decreased
afﬁnity for Wnt3a, suggesting that these residues may deﬁne the
speciﬁcity spectrum of WIF for Wnts. These results suggest that
variants of the WIF-domain might be used for the more speciﬁc
targeting of Wnt family members in various forms of cancer.
2. Materials and methods
(see Supplementary Material)
3. Results
3.1. Characterization of the Wnt–WIF interaction by surface plasmon
resonance spectroscopy
Studies on the interaction of soluble Wnt3a, Wnt4, Wnt5a,
humanWnt7a, Wnt9b and Wnt1 1 with immobilized WIF-domain
by surface plasmon resonance spectroscopy revealed that all these
Wnts had high afﬁnity (1010 M < Kd < 108 M) for the inhibitor
(Fig. 1, Table 1). Our observation that the equilibrium dissociation
constants of the WIF–Wnt interactions are in the 108 M–109 M
range is in agreement with the data of Hsieh et al. [13]; these
authors have found that the interaction of WIF-1 protein with
XWnt8 is characterized by a Kd of 16 nM.
3.2. Effect of mutations of the WIF-domain on its interaction with
Wnts
In our earlier studies we have shown that the WIF-domain of
Wnt inhibitory factor-1 has an alkyl-binding site and suggestedFig. 1. Characterization of the interaction of the WIF-domain of Wnt Inhibitory
Factor-1 with Wnt5a by surface plasmon resonance assays. Various concentrations
of Wnt5a (5 nM, 10 nM, 20 nM, 40 nM and 80 nM) were injected over CM5
sensorchips containing immobilized WIF-domain (at 0 s on the abscissa). The
binding phase lasted 180 s, followed by a washing phase. Association and
dissociation rate constants were calculated by analysis of the sensorgrams of the
binding and washing phases, respectively. For each experiment one set of
representative data of three parallels are shown; in each case SPR response
increased parallel with the increase of analyte concentration.that this site may be involved in binding Wnts activated by fatty
acid modiﬁcation [15]. In the present work we have selected resi-
dues deﬁning/surrounding this binding site for arginine-scanning
mutagenesis (the list of residues subjected to mutagenesis is
shown in Supplementary Table 1). Our motivation for the use of
arginine-scanning mutagenesis was the observation that in the
case of binding sites for hydrophobic ligands the latter approach
appears to be more efﬁcient than alanine-scanning mutagenesis
[16]: replacing a hydrophobic side chain with a positively charged
group causes more drastic changes in binding hydrophobic ligands
than substitution with alanine.
Furthermore, since standard determination of binding constants
by SPR from on- and off-rates (when one of the interacting partners
is immobilized) may not correctly reproduce binding constants in
solution [17], we have used the competition assay format that
may be more reliable in the detection of changes in the afﬁnities
of mutant WIF-domains for Wnts (Fig. 2).
Although we have selected a total of ﬁfteen positions of the
WIF-domain for arginine-scanning mutagenesis, the effect of the
mutations on the WIF-Wnt interaction could not be studied in
the case of the Glu28Arg, Asp45Arg, Phe46Arg, Phe65Arg,
Glu78Arg and Asp86Arg mutants either because Pichiapastoris
failed to express the mutant protein or because the mutant pro-
teins failed to acquire the native fold (Supplementary Table 2).
Substitution of Gln20, Ile31 and His44 with arginine had no effect
on the interaction of the WIF-domain with Wnt5a.
Our solution competition assays have revealed that substitution
of Ile25, Phe27 and Phe42 by arginine resulted in a marked de-
crease in the afﬁnity for Wnt5a (Table 2). Surprisingly, substitution
of Tyr13, Trp15 and Leu32 with arginine increased the afﬁnity of
the WIF-domain for Wnt5a. It is interesting to point out that
Tyr13, Trp15, Ile25, Leu32 and Phe42 were shown to be involved
in interactions with different parts of the polyoxyethylene lauryl
ether, Brij-35 [15]. Based on these results we conclude that the sur-
face of the WIF-domain, identiﬁed as its alkyl-binding site, is crit-
ical for Wnt-binding.
As to the role of these residues in Wnt-binding: one possibility
is that they are part of the Wnt-binding site (i.e. interact directly
with Wnt5a) explaining why their substitution leads to changes
in the Wnt-WIF interaction. However, it is also possible that they
are distant from the Wnt-binding site and their mutation leads
to loss of activity because the mutation causes gross alteration of
the structure of the WIF-domain and this leads to loss of activity.
To minimize the danger of the latter possibility in the present work
we have used a strategy that excludes mutations that may cause
misfolding (see Supplementary File). Most mutant WIF-domains
had CD spectra characteristic of the native fold of the WIF-domain
and also showed sharp thermal transitions with Tm values similar
to that of the wild type protein. Mutant proteins that failed to ac-
quire a stable native fold (as judged by their CD spectra or Tm val-
ues) were excluded from our studies.
Despite these precautions, there is no guarantee that mutation
of a residue-not directly involved in Wnt-binding – may also im-
Fig. 2. Effect of wild type and mutant WIF-domains on the binding of Wnt5a to immobilized wild-type WIF-domain, monitored by surface plasmon resonance. Sensorgrams
of the interactions of immobilized WIF-domain with Wnt5a (20 nM) (A) preincubated with 0 lM, 0.5 lM, 1 lM, 2 lM and 4 lM of wild type WIF-domain; (B) preincubated
with 0 lM, 0.125 lM, 0.25 lM, 1 lM and 4 lM of WIF-Leu32Arg; (C) preincubated with 0 lM, 1 lM, 2 lM, 4 lM and 8 lM of WIF-Phe42Arg. Wnt5a was preincubated with
various concentrations of wild type or mutant WIF-domains for 30 min at room temperature and were injected over CM5 sensorchips containing immobilized wild type WIF-
domain (at 0 s on the abscissa). The binding phase lasted 180 s, followed by a washing phase. Association and dissociation rate constants were calculated by analysis of the
sensorgrams of the binding and washing phases, respectively. In each case SPR response decreased parallel with the increase of WIF concentration. Panel (D) shows the
concentration dependence of the inhibitory effect of WIF-domains as monitored by changes in observed association rate, kobs. Symbols: wild type WIF-domain -d-d; WIF-
L32R -.-.; WIF-F42R -s-s.
Table 2
Effect of mutations of the WIF-domain on its interaction with Wnt5a and Wnt3a. The
ability of soluble wild type or mutant WIF-domains to inhibit binding of Wnt5a or
Wnt3a to immobilized wild type WIF-domain was monitored by competitive SPR
analyses and the IC50 concentrations causing half-maximal inhibition were calculated
from the observed association rates, kobs. The table lists the ratios of IC50 values of
soluble mutant WIF-domains relative to that determined for soluble wild type WIF-
domain on the same chip. The last column expresses the inﬂuence of the mutation on
the speciﬁcity of the WIF-domain for Wnt5a versus Wnt3a. Residue numbering agrees
with that used previously [14] .
Mutation Wnt5a I50 ratio Wnt3a I50 ratio Shift in speciﬁcity
Wild type 1.00 1.00 –
Tyr13Arg 0.40 1.60 4.00
Trp15Arg 0.20 7.07 35.4
Ile25Arg 2.43 7.06 2.91
Phe27Arg 3.30 16.35 4.95
Leu32Arg 0.30 1.80 6.00
Phe42Arg 2.10 2.70 1.29
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Accordingly, we can’t exclude the possibility that substution of
Ile25, Phe27 and Phe42 by arginine decreased the afﬁnity for
Wnt5a through minor distortion of the structure of the WIF-
domain.
In our opinion this interpretation is less likely to hold for muta-
tions of Tyr13, Trp 15 and Leu32 that increased afﬁnity forWnt-binding: since the WIF-domain has an evolutionary estab-
lished structure therefore changes in structure is more likely to im-
pair function than improve it. Furthermore, since residues Tyr13,
Trp15, Ile25, Phe27, Leu32 and Phe42 are all exposed on the sur-
face of the WIF-fold (Fig. 3.), we favor the interpretation that they
are involved in Wnt-binding.
It must be emphasized, however, that these observations do not
tell us anything about the nature of the Wnt-groups (amino acid
side-chains or posttranslational modiﬁcations) that interact with
this surface of the WIF-domain. It seems possible that the subre-
gion of the Wnt-binding site deﬁned by Ile25, Phe27 and Phe42
may bind the palmitoyl group; in this interpretation the introduc-
tion of hydrophilic arginine side-chains weakens the hydrophobic
interaction with the lipid moiety of Wnts. Alternatively, these
hydrophobic residues may serve to interact with amino acid side
chains of Wnts.
The other subregion deﬁned by residues Tyr13, Trp15 and Leu32
(Fig. 3.), however, is unlikely to be involved in palmitoyl-binding
since their substitution with arginines actually increased their efﬁ-
ciency to compete with wild type WIF. It seems more likely that
these residues are critical for interactions with amino acid side-
chains of Wnt5a. This interpretation is supported by the fact that
the effect of these mutations on WIF-Wnt interactions seems to
vary with Wnt (Table 2.). For example, in competition assays the
Tyr13
Trp15
Leu32
Phe27
Ile25
Phe42
Met53
Fig. 3. Surface of the WIF-domain involved in its interaction with Wnt5a, modelled
on the structure of the WIF-domain (PDB 2YGN). Residues whose substitution with
arginine resulted in weaker binding (yellow; Ile25, Phe27, Phe42) and those that
resulted in increased afﬁnity (green; Tyr13, Trp15, Leu32) for Wnt5a are
highlighted. Note that Ile25, Phe27 and Phe42 surround a deep crevice with Met-
53 (highlighted in red) at the bottom. The image was generated by YASARA version
7.10.31.
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Wnt5a by a factor of 5, whereas it decreased its afﬁnity for Wnt3a
by a factor of 7, i.e. it caused a 35-fold shift in speciﬁcity for these
two Wnts (Table 2).
4. Discussion
In the present work we have shown that the alkyl-binding site
of the WIF-domain is critical for its interaction with Wnts: substi-
tution of residues known to interact with the alkyl-moiety of poly-
oxyethylene lauryl ether has altered the afﬁnity of the WIF-domain
for Wnts.
In view of the fact that Wnts are modiﬁed by palmitic acid and
palmitoleic acid [6] it seemed justiﬁed to assume that the alkyl-
binding site of the WIF-domain may serve to bind these groups
[15]. One could argue that a strong afﬁnity for palmitoylated resi-
dues would explain the fact that WIF-1 of a given species has high
afﬁnity for Wnts from distant species [13], or that WIF-1 does not
show marked differences in its afﬁnity for different Wnt paralogs,
although the amino acid sequences of these Wnts show major dif-
ferences (see Table 1). Remarkably, the WIF- domain of WIF-1 can
also regulate signaling by the palmitoylated Hedgehog proteins
[18], although the amino acid sequences of Hedgehog proteins
are not related to those of Wnts.
The alkyl-binding site of the WIF-domain appears to consist of
two distinct subregions: intermolecular NOEs with the aliphatic
CH2 groups of Brij-35 were observed for Ile31, Phe42, Phe46,
whereas the ethyleneglycol part interacted with Leu32, Trp15,
Tyr13 and, with some ambiguity, Ile25 [15]. Interestingly, these
two subregions also differ in the inﬂuence of arginine-substitu-
tions on Wnt-binding: substitutions affecting the ﬁrst region de-
creased the afﬁnity for both Wnt5a and Wnt3a (Table 2),
whereas those affecting the second subregion increased the afﬁnity
for Wnt5a, but in some cases (Tyr13Arg, Trp15Arg, Leu32Arg) de-
creased afﬁnity for Wnt3a.
One possible explanation for these observations is that the ﬁrst
subregion is involved in conserved hydrophobic interactions with
Wnts (possibly, but not necessarily involving conserved lipid moi-eties), whereas the second subregion is involved in interactions
with amino acid side-chains of Wnts that may vary with Wnt.
The fact that substitution of some residues of theWIF-domain with
arginine (Tyr13, Trp15, Leu32) had opposite effect on its afﬁnity for
Wnt5a and Wnt3a indicates that the WIF-binding sites of these
Wnts show signiﬁcant sequence variation.
In a recent study Malinauskas et al. [14] have solved the crystal
structure of the WIF-domain and have shown that a lipid, 1,2-
dipalmitoylphosphatidylcholine (DPPC), was an integral part of
the WIF-domain core. The acyl chains of DPPC ﬁtted within the
WIF-domain core, whereas its phosphatidylcholine head group
was exposed to the surface. The ethylene group of the head group
formed a hydrophobic interaction with Phe42 (Phe66 in the
authors’ numbering), the glycerol backbone packed against Ile25
(Ile49 in the authors’ numbering). (Note that these residues also
interact with polyoxyethylene lauryl ether, see above.) Based on
these results, Malinauskas et al. [14] have argued that the lipid-
binding capacity of the WIF-domain is saturated with DPPC, there-
fore the hydrophobic pocket of the WIF-domain is unlikely to serve
as a binding site for palmitoyl or palmitoleoyl chains of Wnts
since’’ the exchange of the integral WIF-1-bound diacyl lipid with
a single-chain Wnt3a-linked lipid would be energetically very
unfavorable in the aqueous extracellular environment’’ [14]. In
support of this conclusion they use the observation that WIF did
not bind 15 different, biologically abundant lipids. In our view this
argument is valid in the case of simple lipids (that interact only
with residues forming the lipid-binding site) but may not be valid
for ‘complex’ lipids such as palmitoylated Wnts where tight bind-
ing is also mediated by interactions of amino acid side-chains of
the two proteins.
Malinauskas et al. [14] have also performed mutagenesis stud-
ies to map out areas of the WIF-domain surface involved in Wnt3a
recognition. They have mutated 15 surface-exposed positions to
introduce asparagine-linked glycosylation sites on different sur-
faces of the WIF-domain and six additional single-residue muta-
tions to investigate their effect on WIF-1-Wnt3a recognition. The
majority of mutations caused no signiﬁcant effect on the recogni-
tion of Wnt3a. Only three mutations introducing N-linked glyco-
sylation sites at positions Phe149 (Phe174), Phe27 (Phe51) and
Glu127 (Glu151) and the substitution of Met53 (Met77) with tryp-
tophan caused more than 50% decrease in the inhibitory capacity of
the molecule (numbers in parenthesis refer to residue numbering
used by Malinauskas et al.). Based on these ﬁndings the authors
identiﬁed a discontinuous area as a putative Wnt3a-binding site
that wraps around the WIF-domain.
We wish to emphasize that introduction of novel N-glycosyla-
tion sites permits only low resolution mapping of binding sites
since the large carbohydrate moieties introduced may exert their
effect at points that are spatially distant from the point of muta-
genesis. In view of these considerations we note with interest that
residues Phe149 (Phe174) and Phe27 (Phe51) – where N-glycosyl-
ation reduces afﬁnity by 60–70% – are at the periphery of the
Wnt-binding site deﬁned by our mutagenesis studies.
Within the putative Wnt-binding site deﬁned by Malinauskas
et al. [14], the effects of the Met53Trp (Met77Trp) mutation high-
lights the importance of the region of the alkyl-binding site. Met53
is partially buried at the entrance to the lipid-binding cavity
(Fig. 3). Although the mutation did not cause major long-range per-
turbations in the structure of the WIF-fold, it led to a signiﬁcant
reduction in the ability of the WIF-domain to inhibit Wnt3a signal-
ing [14]. This observation is in harmony with our conclusion that
the lipid-binding site is critical for Wnt-binding.
Accepting that the surface deﬁned by residues Tyr13, Trp15,
Ile25, Phe27, Leu32 , Phe42 (and Met53) is involved in Wnt-
binding it may appear surprising that mutation of none of these
residues eliminated the binding of the WIF-domain for Wnt5a or
3126 L. Bányai et al. / FEBS Letters 586 (2012) 3122–3126Wnt3a. One possible explanation for this failure is that - in analogy
with the Wnt-Frizzled interaction – Wnts may bind the WIF-
domain at two distinct sites. As shown by Janda et al., [19] Wnts
have an unusual two-domain structure resembling a ‘‘hand’’ with
‘‘thumb’’ and ‘‘index ﬁngers’’ extended that grasp the Wnt-binding
domain of Frizzled receptors at two distinct binding sites. One site
is dominated by a palmitoleic acid lipid group, in the second
binding site the conserved tip of Wnt’s ‘‘index ﬁnger’’ forms hydro-
phobic amino acid contacts with a depression on the opposite side
of theWnt-binding domain of Frizzled receptors. It seems plausible
to assume that WIF can efﬁciently block the binding of Wnts to
Frizzled receptors if it binds to both the ‘‘thumb’’ and the ‘‘index
ﬁnger’’ of Wnts.
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